Tamoxifen safety study for cystic fibrosis patients not on modulators
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study tests whether tamoxifen, a medicine usually used for breast cancer, is safe for adults with cystic fibrosis who cannot take CFTR modulators. It aims to see if tamoxifen can be a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have cystic fibrosis and do not have a type that can be treated with CFTR modulators
- Your lung function is between 40% and 90% of what is expected for your age, sex, and height
- Your CF treatments have been stable for the past 28 days
- You have not had a lung flare-up in the last 3 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tamoxifen, a hormone-blocking pill, can prevent pancreatic cysts from turning into cancer in people who are not having surgery to remove the cyst right away.
This trial tests how well cystic fibrosis (CF) medicine works for you using an “n-of-1” approach, meaning you try treatments in a structured, repeated way to see what helps you most. It may help your care team choose the best option for your specific CF genetics and health status.
This study tests whether people with cystic fibrosis who are already on a triple combination CFTR modulator can stay on their treatment without interruptions or problems. It aims to make sure everyone gets the best, most consistent treatment for their CF.
This study tests new treatments for cystic fibrosis in people who cannot take or choose not to take current CFTR modulators. It aims to find better options for managing CF.
This study measures how CFTR medicine behaves in the body during pregnancy and after delivery while breastfeeding. The results may help confirm dosing and safety information for people with cystic fibrosis.
This study tests whether a special nutrition supplement can help people with cystic fibrosis who also have pancreatic problems. It is for adults 18 and older who are already taking a CFTR modulator and have normal liver lab results.
Hear when a new Cystic Fibrosis - Complete trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.